Navigation Links
'Selective strategy' recommended for CT scans in emergency departments
Date:1/18/2011

CINCINNATI--Emergency medicine researchers with the University of Cincinnati (UC) are advocating a new strategy for diagnosing a common but dangerous condition in the emergency room.

Pulmonary embolism, or PE, is a potentially lethal disease in which a blood clot, usually from the legs, travels to the lungs and becomes lodged in a pulmonary artery. But the most common way of testing for PEs, a computed tomography angiography (CTA), comes with so many side effects that researchers in emergency medicine are now looking for ways to reduce use of the test.

In a CTA, a contrast dye is first injected into a vein. As the dye circulates through the body, a CT scan is used to take detailed images of the vessels.

"The use of CTA for blood clots has increased 235 percent between 1991 and 2002," says Michael Ward, MD, UC emergency medicine operations research fellow. "However, recent literature has shown there are significant risks associated with CTA, including radiation, severe allergic reaction and kidney failure from the contrast dye.

"As more risks are discovered, the development of diagnostic strategies to reduce the use of CTA has become extremely important."

In a study done June 2010, Ward used existing data to predict costs and results for two models of PE diagnosis. One model tests all patients for PE using a CTA. Another uses compression ultrasound to first test for deep vein thrombosis (DVT), the formation of a blood clot in the leg.

"The diagnosis of a DVT, together with symptoms of PE, almost certainly suggests a PE," says Ward. "If the test for DVT was positive, the patient was admitted to the hospital for PE and started treatment with anticoagulants. If the test was negative, patients had a CTA performed to evaluate for PE."

In the study, researchers used a computer decision model to evaluate a typical patient being evaluated in the ED with signs and symptoms of a PE. Using the model, Ward and his colleagues were able to test different scenarios to see how each strategy held up.

The model showed that the selective CT strategy resulted in both a life expectancy increase for patients and a cost savings for hospitals. Ward's analysis is published in the January issue of Academic Emergency Medicine.

"Our work suggests that a PE diagnostic strategy that uses compression ultrasound followed by selective CTA is not only cost-effective, but may be a way to reduce the incidence of adverse affects associated with the CTA," says Ward.

Ward says that an ultrasound strategy has been used in the ED before, but only as a rule-out strategy, rather than the rule-in approach tested in this study. With almost half the CTAs in the U.S. in 2006 performed in the emergency room, he says a reduction of unnecessary CTA imaging in a cost-effective manner can have a strong impact for both patients and health care providers.


'/>"/>

Contact: Katy Cosse
kathryn.cosse@uc.edu
513-558-0207
University of Cincinnati Academic Health Center
Source:Eurekalert

Related medicine news :

1. Selective inhibition of BMK1 suppresses tumor growth
2. With proper planning, selective rather than mass vaccination can provide immunity against flu
3. Governor Rendell Proposes Budget With No Tax Increase, More Money for Public Schools, Strategy for Jobs, Plan to Address Future Deficits
4. SOKO Fitness & Spa Group Broadens Geographic Expansion Strategy
5. Keenan Chief Strategy Officer Selected to Join Editorial Board of Payers & Providers
6. Data Strategy Announces SurePath Services Offering for EMC Avamar
7. New strategy produces promising advance in cancer vaccines
8. New Cancer-Fighting Strategy Focuses On Signaling Molecules
9. Targeting leukemia cells gene addiction presents new strategy for treatment
10. Novel Parkinson's Treatment Strategy Involves Cell Transplantation
11. A new strategy normalizes blood sugars in diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... ... Lori G. Cohen and Sara K. Thompson , shareholders in global law ... 21st Drug & Medical Device Litigation Conference , taking place in New York Dec. ... chairs the firm’s Pharmaceutical, Medical Device & Health Care Litigation Practice and the Trial ...
(Date:12/2/2016)... , ... December 02, 2016 , ... Advanced Inc., a ... has appointed Jason Bice, CPA, MBA to serve as Advanced Inc.’s Chief Financial Officer, ... Inc. , Jason brings extensive financial and operational leadership experience to Advanced Inc. ...
(Date:12/2/2016)... ... ... With the number of pain management programs available for people suffering with ... that works for them. When an inventor from Suisun City, Calif., was unsuccessful in ... share it with others. , He developed a prototype for PRO GO MASSAGE to ...
(Date:12/2/2016)... ... December 02, 2016 , ... CloudLIMS.com, a ... SaaS LIMS, CloudLIMS Lite. CloudLIMS Lite helps biobanks, clinical, research and testing laboratories ... and disposal. The new version is a faster and a more efficient product, ...
(Date:12/2/2016)... ... 02, 2016 , ... Yisrayl Hawkins, at The House of Yahweh in Abilene, ... into Bible Prophecy. Yisrayl says this generation, known as the Last Generation, started in ... the details line up exactly with Bible Prophecy – a protected way for those ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... , Dec. 2, 2016  Maxor National Pharmacy Services, ... of Pharmaceutical Specialties, Inc. ("PSI").  The combination of ... Georgia -based PSI bring together both company,s clinical ... manufacturers, and payers an industry-leading specialty pharmacy. About ... , , ...
(Date:12/2/2016)... 2, 2016 Lianluo Smart Limited (Nasdaq: ... Company") which develops, markets and sells medical devices ... China and international markets, recently attended ... Treatment New Progress Forum, co-hosted by the Institute ... , Guangdong Provincial People,s Hospital and Cardiology ...
(Date:12/2/2016)... Dec. 1, 2016 The concept of rare diseases ... given to this sector has been taking shape in ... the political aspects and initiatives related to orphan medicinal products ... the level of member states individually. Many member states in ... the space of orphan medicinal products, the result of which ...
Breaking Medicine Technology: